Chemotherapy and Immunotherapy in Urologic Oncology, 1st ed. 2021 A Guide for the Advanced Practice Provider
Langue : Anglais
Coordonnateurs : Trabulsi Edouard J., Lallas Costas D., Lizardi-Calvaresi Anne E.
This book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune check point and immunomodulatory agents, and targeted therapies. Written by experts in the field, the book also reviews current chemotherapy and immunotherapy regimens for genitourinary malignancies and discusses indications, outcomes, and toxicities, as well as clinical trial concepts. Each of the book?s chapters offers a bulleted box of clinical pearls on the particular role of the APP.
Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider is a resource for urologists, uro-radiologists, medical clinicians and family practitioners alike, familiarizing its audiences with systemic therapy regimens for urologic malignancies, as well as their expected outcomes and side effects.
Introduction: Integration of APP into Urologic Oncology Practice.- Overview and Active Surveillance of Prostate Cancer.- Monitoring and Managing Men Following Initial Treatment of Prostate Cancer.- Radical Prostatectomy and Survivorship after Radical Prostatectomy.- Multimodal Treatment Plans in Prostate Cancer.- Radiotherapy for Prostate Cancer.- Androgen Deprivation Treatment.- Second Generation Androgen Targeted Agents.- Chemotherapy and prostate cancer.- Radiopharmaceuticals for Prostate Cancer.- Immunotherapy and Novel Agents on the Horizon for the Treatment of Prostate Cancer.- Bladder Cancer.- Intravesical Therapy for Non Muscle Invasive Urothelial Carcinoma.- Bladder Cancer: Muscle Invasive Disease.- Chemoradiation Bladder Preservation.- Metastatic Bladder Cancer and the Use of Cisplatin Chemotherapy.- Immunotherapy for Metastatic Urothelial Cancer.- Novel and experimental Strategies in the treatment of Metastatic Urothelial Carcinoma.- Upper Tract Urothelial Carcinoma.- Kidney Cancer and Its Treatment.- Targeted Therapies for Treatment of Metastatic Renal Cell Carcinoma.- Immune Therapies for Metastatic Kidney Cancer.- Novel Therapies for Renal Cell Carcinoma.- Testicular Cancer.- Penile Cancer.
Edouard J. Trabulsi
Director, Multidisciplinary Genitourinary Oncology Center
Director, Division of Urologic Oncology, Department of Urology
Co-Director, Prostate Diagnostic Center
Professor and Vice Chair of Research
Department of Urology
Sidney Kimmel Medical College at
Thomas Jefferson University
Philadelphia, PA
USA
Costas D. Lallas
Professor and Vice Chair of Academic Affairs
Department of Urology
Sidney Kimmel Medical College at
Thomas Jefferson University
Philadelphia, PA
USA
Anne E. Lizardi-Calvaresi
Director of Clinical Operations
Urology Nurse Practitioner
Sidney Kimmel Medical College at
Thomas Jefferson University
Philadelphia, PA
USA
One of few texts geared toward advanced practice providers and urologic care
Written by experts in the field
Each chapter includes a list of clinical pearls and key takeaways
Date de parution : 09-2020
Ouvrage de 307 p.
15.5x23.5 cm
Thèmes de Chemotherapy and Immunotherapy in Urologic Oncology :
© 2024 LAVOISIER S.A.S.
